You just read:

Stealth BioTherapeutics Provides Update on Phase 3 Trial of Elamipretide in Primary Mitochondrial Myopathy

News provided by

STEALTH BIOTHERAPEUTICS INC.

Dec 20, 2019, 08:00 ET